Skip to main content

Peer Review reports

From: A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma

Original Submission
10 Nov 2009 Submitted Original manuscript
23 Nov 2009 Author responded Author comments - Tim Greten
Resubmission - Version 2
23 Nov 2009 Submitted Manuscript version 2
7 Dec 2009 Reviewed Reviewer Report - Yo-ichi Yamashita
7 Dec 2009 Reviewed Reviewer Report - Fabio Grizzi
15 Dec 2009 Reviewed Reviewer Report - paal fr brunsvig
4 Mar 2010 Author responded Author comments - Tim Greten
Resubmission - Version 3
4 Mar 2010 Submitted Manuscript version 3
7 Apr 2010 Reviewed Reviewer Report - paal fr brunsvig
30 Apr 2010 Author responded Author comments - Tim Greten
Resubmission - Version 4
30 Apr 2010 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
7 May 2010 Author responded Author comments - Tim Greten
Resubmission - Version 6
7 May 2010 Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
12 May 2010 Author responded Author comments - Tim Greten
Resubmission - Version 8
12 May 2010 Submitted Manuscript version 8
Publishing
17 May 2010 Editorially accepted
17 May 2010 Article published 10.1186/1471-2407-10-209

You can find further information about peer review here.

Back to article page